Korea has strong R&D powerhouse, Pfizer management says

Published: 2006-09-13 06:59:00

Updated: 2006-09-13 06:59:00

"I am really surprised at Korean researchers and facilities for their top-notch expertise in basic and clinical testing," said Declan Doogan, vice president of Pfzier Inc. prior to his departure immediately after his 20 delegates attended BIO KOREA 20006.

In meeting with Pfizer Korea officials...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK